Investor Type | Firm |
Type of Fund | VC |
Industries | HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Woman Focused |
Stages | Pre-Seed, Seed, Early Stage, Series A |
Investing | United States |
Investment Range | $1,000 - $8,000 |
Investment Sweet Spot | $5,000 |
Sonder Capital is a venture capital firm specializing in early-stage investments, focusing on the medtech startup sector. They are dedicated to investing in innovative technologies that have the potential to set new standards of care. With particular interest in medical device, diagnostic, and healthtech industries, Sonder Capital positions itself as a 'Foundational Investor.' This means that they commit their resources and expertise early in a startup's journey, helping guide and support the companies from their inception through to acquisition or an initial public offering (IPO). They actively engage with the companies they invest in, offering strategic advice and support beyond financial investment. Their involvement at the initial stages allows them to influence critical early decisions, contributing to the long-term success of these ventures. Sonder Capital's investment portfolio is centered around transformational innovations enabled by technology, with solutions that impact patient outcomes, enhance access to care, or revolutionize business models. They target companies that exhibit the potential for significant growth, often supported by the opportunity for achieving a market capitalization of $1 billion or more. Furthermore, Sonder Capital emphasizes a commitment to diversity, recognizing an industry gap in the venture community's support for female and minority-run businesses. To bridge this gap, they accept direct pitch requests from CEOs and founders who are women, minorities, or other underrepresented individuals in the industry, even without a referral. They also track diversity metrics to ensure support and involvement with diverse entrepreneurs. Their investment parameters include a maximum investment of $8 million, with a minimum of $1 million and a 'sweet spot' of around $5 million. The types of funding rounds they specialize in include Pre-Seed, Seed, Early Stage, and Series A rounds. The Sonder Capital team brings decades of operational experience in the medtech field, leveraging their background as founders, executives, and board members to overcome challenges and succeed in this competitive sector.